Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth B Gottlin

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Frontiers in Oncology|January 25, 2024
Perspective: rethinking therapeutic strategies in oncologyEdward F Patz, Elizabeth B Gottlin, George R Simon
Cancer Immunology, Immunotherapy : CII|February 26, 2025
A tumor-binding antibody with cross-reactivity to viral antigensMichael J Campa, Elizabeth B Gottlin, Kevin Wiehe, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Intracellular expression of Peptide fusions for demonstration of protein essentiality in bacteriaR Edward Benson, Elizabeth B Gottlin, Dale J Christensen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 28, 2017
Rethinking Autoantibody Signature Panels for Cancer DiagnosisMichael J Campa, Elizabeth B Gottlin, James E Herndon, et al.
Plos One|June 16, 2021
Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosisRyan T Bushey, Elizabeth B Gottlin, Michael J Campa, et al.
Cancer Immunology Research|July 29, 2015
Complement Factor H Antibodies from Lung Cancer Patients Induce Complement-Dependent Lysis of Tumor Cells, Suggesting a Novel Immunotherapeutic StrategyMichael J Campa, Elizabeth B Gottlin, Ryan T Bushey, et al.
Seminars in Immunology|January 18, 2025
Complement regulators as novel targets for anti-cancer therapy: A comprehensive reviewRuchi Saxena, Elizabeth B Gottlin, Michael J Campa, et al.
Plos One|November 9, 2018
A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancerJeffrey R Ashton, Elizabeth B Gottlin, Edward F Patz, et al.
Journal of Biomolecular Screening|January 28, 2009
Isolation of novel EGFR-specific VHH domainsElizabeth B Gottlin, Xiangrong Guan, Charles Pegram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2010
Complement factor H autoantibodies are associated with early stage NSCLCNita Amornsiripanitch, Shaolin Hong, Michael J Campa, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|January 25, 2024
Perspective: rethinking therapeutic strategies in oncologyEdward F Patz, Elizabeth B Gottlin, George R Simon
Cancer Immunology, Immunotherapy : CII|February 26, 2025
A tumor-binding antibody with cross-reactivity to viral antigensMichael J Campa, Elizabeth B Gottlin, Kevin Wiehe, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Intracellular expression of Peptide fusions for demonstration of protein essentiality in bacteriaR Edward Benson, Elizabeth B Gottlin, Dale J Christensen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 28, 2017
Rethinking Autoantibody Signature Panels for Cancer DiagnosisMichael J Campa, Elizabeth B Gottlin, James E Herndon, et al.
Plos One|June 16, 2021
Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosisRyan T Bushey, Elizabeth B Gottlin, Michael J Campa, et al.
Cancer Immunology Research|July 29, 2015
Complement Factor H Antibodies from Lung Cancer Patients Induce Complement-Dependent Lysis of Tumor Cells, Suggesting a Novel Immunotherapeutic StrategyMichael J Campa, Elizabeth B Gottlin, Ryan T Bushey, et al.
Seminars in Immunology|January 18, 2025
Complement regulators as novel targets for anti-cancer therapy: A comprehensive reviewRuchi Saxena, Elizabeth B Gottlin, Michael J Campa, et al.
Plos One|November 9, 2018
A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancerJeffrey R Ashton, Elizabeth B Gottlin, Edward F Patz, et al.
Journal of Biomolecular Screening|January 28, 2009
Isolation of novel EGFR-specific VHH domainsElizabeth B Gottlin, Xiangrong Guan, Charles Pegram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2010
Complement factor H autoantibodies are associated with early stage NSCLCNita Amornsiripanitch, Shaolin Hong, Michael J Campa, et al.
Pageof 3